Nine Monthly Results Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 6.12% vs 27.21% in Dec 2024
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is -29.64% vs 157.96% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 10.79% vs 107.75% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 11.43% vs 16.67% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Jagsonpal Pharma With
Figures in Cr
Standalone Nine Monthly Results
Change(INR)
Change(%)
Net Sales
223.03
352.57
-129.54
-36.74%
Other Operating Income
0.00
0.00
0.00
Total Operating income
223.03
352.57
-129.54
-36.74%
Raw Material Cost
13.13
153.49
-140.36
-91.45%
Purchase of Finished goods
69.30
46.54
22.76
48.90%
(Increase) / Decrease In Stocks
-1.82
0.75
-2.57
-342.67%
Employee Cost
55.20
50.14
5.06
10.09%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
3.12
0.00
3.12
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
37.17
45.98
-8.81
-19.16%
Total Expenditure (Excl Depreciation)
176.10
296.90
-120.80
-40.69%
Operating Profit (PBDIT) excl Other Income
46.93
55.67
-8.74
-15.70%
Other Income
8.83
16.73
-7.90
-47.22%
Operating Profit (PBDIT)
55.76
72.40
-16.64
-22.98%
Interest
0.78
0.74
0.04
5.41%
Exceptional Items
-2.08
0.04
-2.12
-5,300.00%
Gross Profit (PBDT)
52.90
71.70
-18.80
-26.22%
Depreciation
7.13
4.05
3.08
76.05%
Profit Before Tax
45.76
67.67
-21.91
-32.38%
Tax
11.44
16.23
-4.79
-29.51%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
34.32
51.43
-17.11
-33.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
34.32
51.43
-17.11
-33.27%
Equity Capital
13.36
94.00
-80.64
-85.79%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
21.04%
15.79%
0.00
5.25%
Gross Profit Margin
23.72%
20.34%
0.00
3.38%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 223.03 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 6.12% vs 27.21% in Dec 2024
Nine Monthly - Standalone Net Profit
Standalone Net Profit 34.32 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -29.64% vs 157.96% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.93 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 10.79% vs 107.75% in Dec 2024
Nine Monthly - Interest
Interest 0.78 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 11.43% vs 16.67% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.04%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
